Columbamine suppresses proliferation and invasion of melanoma cell A375 via HSP90-mediated STAT3 activation

Journal of Receptor and Signal Transduction Research
Tao YangHuan Ke

Abstract

The goal of this study is to explore the effects of columbamine in melanoma cells and the signaling pathway involved. Human melanoma cell line A375 cells were used in this study. Cell proliferative ability was detected by MTT assay and clone formation assay. Cell migration and invasion were measured by wound healing assay and transwell assay, respectively. Protein expression was examined by Western blotting. Columbamine reduced cell proliferative ability and the number of clone spots in A375 cells. Western blotting results demonstrated that expression of cleaved caspase 3, an activated cell death protease, was upregulated by 20 and 50 µM of columbamine. Wound healing results showed that the scratch width was wider in cell treated with 20 and 50 µM of columbamine than that in cell treated with 0 and 10 µM of columbamine. Phosphorylation of STAT3 and expression of HSP90 was also repressed by columbamine in a concentration-dependent manner. Overexpression of HSP90 attenuated the inhibition of cell proliferation, migration and invasion induced by columbamine. Columbamine inhibited melanoma cell proliferation, migration, and invasion in A375 cells through inactivation of STAT3, which is mediated by HSP90.

References

Sep 12, 1997·Science·J E Darnell
Feb 1, 2003·Biochemical and Biophysical Research Communications·Noriko SatoTadashi Matsuda
Nov 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M M McCarthyH M Kluger
Jul 28, 2010·Archives of Pharmacal Research·Xiaohua LiuWeidong Zhang
Aug 10, 2011·Current Medicinal Chemistry·M ZhaoF-H Gao
Nov 20, 2014·Nature·Brian Owens
Feb 24, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Karissa M JohnstonStuart Peacock
Nov 30, 2016·BioFactors·Saeideh MomtazSeyed Mohammad Nabavi
Feb 22, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine G KohnChristopher R Flowers
Jul 18, 2017·Expert Opinion on Investigational Drugs·Andrea L A WongBoon-Cher Goh
Jan 20, 2018·Scientific Reports·Jingtong PanYuehong Xu
Apr 18, 2018·Nature Communications·Daniel Andreas RutzJohannes Buchner
Jan 25, 2019·Current Treatment Options in Oncology·Kenjiro Namikawa, Naoya Yamazaki
Apr 4, 2019·American Journal of Physiology. Renal Physiology·Jesse PaceSandeep K Mallipattu
Apr 9, 2019·Cell Biology International·Dorota W KuleszaBozena Kaminska
Jun 28, 2019·Journal of Surgical Oncology·Conor H O'Neill, Charles R Scoggins
Oct 30, 2019·Apoptosis : an International Journal on Programmed Cell Death·Aleksandra Mielczarek-LewandowskaMalgorzata Czyz
Nov 23, 2019·The Surgical Clinics of North America·Stephanie CarrJessica Wernberg
Dec 1, 2019·European Journal of Medicinal Chemistry·Tamer S KaoudMohamed Abdel-Aziz
Jan 24, 2020·European Journal of Medicinal Chemistry·Thadeu E M M CostaCarmen Penido
Feb 6, 2020·International Journal of Molecular Sciences·Francesca Varrone, Emilia Caputo
Mar 1, 2020·Cell Communication and Signaling : CCS·Jia-Hui MaXia Li
Apr 3, 2020·International Journal of Molecular Sciences·Vera PetrovaViktor Umansky
Apr 4, 2020·Genes & Development·Jingyin YueRamin Shiekhattar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.